In-licensing agreement with Cancer Research Technology on novel TLR agent

Wed, 06/20/2007 - 18:30

Innate Pharma S.A. announced it has entered into a in-licensing agreement with Cancer Research Technology (CRT) on novel TLR agent.

PR in english	39.21 KB
CP en français	40.23 KB